Search:
This item requires a subscription.
Diet, salicylates and their effect on prostate cancer BJCM, Volume 3, Number 1.
Although the prognosis of indolent prostate cancer is good, patients with slowly progressive disease are less satisfied with surveillance alone.1,2 In this group in particular, there is enormous interest among patients and advocacy groups in finding a safe, patient-acceptable nutritional addition to surveillance.3 Halting the progress of the disease with dietary manipulation, or slowing the rate of progression by two to three years in an elderly population, could avoid the toxicities of radical therapies.
To view this item, select one of the options below:
Purchase access
Sign in
email address
Password
Important
All the articles are in PDF format.
To view the articles you will need Adobe Acrobat Reader.
To download a copy, free of charge, please click here.